KPL-301

· Kiniksa Pharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPL-301, covering 2023-10-17 to 2023-10-17. Get the full timeline:

Most recent: Clinical Trial Update: KPL-301 for Subjects With Giant Cell Arteritis [Phase 2]